UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000037671
Receipt No. R000042962
Scientific Title The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low back
Date of disclosure of the study information 2019/08/18
Last modified on 2020/10/12 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low back
Acronym The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low back
Scientific Title The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low back
Scientific Title:Acronym The efficacy evaluation of the dietary supplement on discomfort, bending and stretching of the low back
Region
Japan

Condition
Condition None
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the efficacy of ingestion of the dietary supplement containing proteoglycan for 12 weeks on discomfort, bending and stretching of the low back
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes JLEQ
Key secondary outcomes QOL questionnaire
Low back range of motion
Trunk muscle strength

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Ingestion of test food containing proteoglycan for 12 weeks
Interventions/Control_2 Ingestion of placebo food for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) Males and females aged 40 and over
(2) Subjects who have continuous low back discomfort for 3 months or more
(3) Subjects who have habit of sleeping on bedding alone
(4) Subjects with narrow values on low back range of motion
Key exclusion criteria Subjects
(1) who have low back pain due to pain in other joints
(2) who are suspected gouty attack with hyperuricemia
(3) who have positive rheumatoid factors on the screening test or may have rheumatic pain
(4) who have performed arthroplasty on the low back or need it
(5) who regularly take health food which may affect joints or muscles
(6) who take medicine regularly
(7) who have been performed nerve block injection within a year before the screening test or need to be done in the study period
(8) who get an intense exercise to make excessive load on the body
(9) who have a history of disorders affecting the evaluation of effectiveness such as fracture of the low back and acute low back pain within a year before the screening test
(10) who regularly use a cane, a supporter of the low back or a corset
(11) who periodically conduct actions that may affect the evaluation of effectiveness
(12) who are under treatment of diseases that may affect the evaluation of effectiveness
(13) who have severe diseases or have a history of such serious disorders
(14) who are under treatment or have a history of mental diseases
(15) who have unsteady lifestyle or who work manual labor
(16) who drink a lot
(17) who have possibilities for emerging allergy onset related to the study
(18) who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(19) who have participated in other clinical study within a month before the screening test or who intend to participate in the study period
(20) who are in a pregnancy or lactation period in the study period
(21) who are judged as unsuitable due to lifestyle questionnaire
(22) who regularly smoke
(23) who are judged as unsuitable for the study by investigator for other reasons
Target sample size 54

Research contact person
Name of lead principal investigator
1st name Yukihiro
Middle name
Last name Takase
Organization DyDo DRINCO, INC.
Division name Healthcare Business Department
Zip code 530-0005
Address 2-7, Nakanoshima 2-chome, Kita-ku, Osaka, Japan
TEL 06-6222-2600
Email takase@dydo.co.jp

Public contact
Name of contact person
1st name Takashi
Middle name
Last name Nakagawa
Organization TTC Co., Ltd.
Division name Clinical Research Planning Department
Zip code 150-0021
Address Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo
TEL 03-5459-5329
Homepage URL
Email t.nakagawa@ttc-tokyo.co.jp

Sponsor
Institute TTC Co., Ltd
Institute
Department

Funding Source
Organization DyDo DRINCO, INC.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Aisei Hospital Ueno Clinic Research Ethics Committee
Address 2-18-6, Higashiueno, Taitou-ku, Tokyo
Tel 03-6455-0880
Email t.saito@ttc-smo.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 08 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 54
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 06 Month 27 Day
Date of IRB
2019 Year 06 Month 27 Day
Anticipated trial start date
2019 Year 08 Month 19 Day
Last follow-up date
2019 Year 12 Month 14 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 08 Month 13 Day
Last modified on
2020 Year 10 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042962